About Xspray

Xspray has created a unique technology to develop improved and generic versions of pre-existing and well established drugs. Xspray primarily develops protein kinase inhibitors for a targeted treatment of cancer.

Read more


RightSize, Xspray’s patented technology, can improve all of the challenges posed against the PKI’s and enables the development of patented product candidates with better therapeutic profile than currently available products.

Read more

Through its unique technology, Xspray’s vision is to establish itself as a leading global company for generic and enhanced variants of established protein kinase inhibitors for targeted cancer treatments. The objective is to increase the life quality of patients and chances of survival, as well as reducing the cost of burden in society.


Xspray Pharma AB
Råsundavägen 12
169 67 Solna

+46 (0)8 730 37 00

Check the map